Back

Is it possible the use of sacubitril/valsartan in HFrEF and hemodialysis?

27 May 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Basic Science - Chronic Heart Failure – Pathophysiology and Mechanisms Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2018

About the speaker

Photo
Mr Jose Morgado

University Hospital of Virgen Macarena, Seville (Spain)

46 More presentations in this session

Presentation thumbnail
Professor H. Sabbah (Detroit, US)
Abstract Slides
Presentation thumbnail
Mr M. Lichy (Bratislava, SK)
Abstract
Presentation thumbnail
Doctor M. Gawor (Warsaw, PL)
Abstract
Presentation thumbnail
Doctor M. Vanderheyden (Aalst, BE)
Abstract
Presentation thumbnail
Mr J. Berg (Lund, SE)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Basic Science - Chronic Heart Failure – Pathophysiology and Mechanisms

The Event

Event poster

Heart Failure 2018

27 May 2018 08:30 CET
You may be interested in
thumbnail
Webinar
Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023
thumbnail
Congress Session
Transforming heart failure care: unlocking new pathways

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources